Theravance Biopharma Inc
NASDAQ:TBPH
Theravance Biopharma Inc
Income from Continuing Operations
Theravance Biopharma Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theravance Biopharma Inc
NASDAQ:TBPH
|
Income from Continuing Operations
-$55.2m
|
CAGR 3-Years
43%
|
CAGR 5-Years
24%
|
CAGR 10-Years
10%
|
See Also
What is Theravance Biopharma Inc's Income from Continuing Operations?
Income from Continuing Operations
-55.2m
USD
Based on the financial report for Dec 31, 2023, Theravance Biopharma Inc's Income from Continuing Operations amounts to -55.2m USD.
What is Theravance Biopharma Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
10%
Over the last year, the Income from Continuing Operations growth was 41%. The average annual Income from Continuing Operations growth rates for Theravance Biopharma Inc have been 43% over the past three years , 24% over the past five years , and 10% over the past ten years .